Zentalis Pharmaceuticals Executives Make Significant Share Sales in February 2026.

Zentalis Pharmaceuticals, Inc. [ZNTL] recently announced that Chief Medical Officer Bruns Ingmar sold 2962 shares at $2.43 per share on February 6, 2026, and also sold 335 shares at $2.39 per share on February 9, 2026. Director, CEO, and President Eastland Julia Marie sold 7866 shares at $2.43 per share on February 6, 2026, and also sold 889 shares at $2.39 per share on February 9, 2026. PAO and PFO Vultaggio Vincent sold 29951 shares at $2.43 per share on February 6, 2026, and also sold 3379 shares at $2.39 per share on February 9, 2026, as well as 6894 shares at $2.42 per share on February 10, 2026.